JUST-IN: Federal Govt Grants Provisional Approval For Oxford Malaria Vaccine
The federal government of Nigeria has granted provisional approval for the R21/Matrix malaria vaccine developed by the Oxford University.
Stay updated with breaking news from Collaborative Registration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The federal government of Nigeria has granted provisional approval for the R21/Matrix malaria vaccine developed by the Oxford University.
The National Agency for Food and Drug Administration and Control (NAFDAC) said it has granted approval to Serum Institute Pvt. Ltd. (SIIPL) R21 malaria vaccine for the treatment of malaria in Nigeria. The Director-General, Prof. Mojisola Adeyeye, said this at a news conference on Monday in Abuja. She said that the granting of registration/approval was
Program/Project Management Consultancy in Nigeria about HIV/Aids, requiring 10+ years of experience, from Jhpiego; closing on 25 Jan 2021